UHS
64
-3
ICE
69
2
SYF
60
-2
DGX
46
3
MDT
60
3
LRCX
50
-5
VIX
46
-3
CL
56
2
SCHW
74
3
PFG
43
-2
ADP
79
2
EMN
43
-6
HSIC
48
-2
IRM
46
4
AMAT
54
-3
AA
31
-3
BA
47
-3
ADBE
60
3
PFE
48
2
HPE
49
-5
UHS
64
-3
ICE
69
2
SYF
60
-2
DGX
46
3
MDT
60
3
LRCX
50
-5
VIX
46
-3
CL
56
2
SCHW
74
3
PFG
43
-2
ADP
79
2
EMN
43
-6
HSIC
48
-2
IRM
46
4
AMAT
54
-3
AA
31
-3
BA
47
-3
ADBE
60
3
PFE
48
2
HPE
49
-5
Financhill
Back

Berkshire Hathaway Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
35

BRK.A
Berkshire Hathaway

Last Price:
$755,815.00
Seasonality Move:
3.82%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$16.93
Seasonality Move:
0.23%
Sell
35
Berkshire Hathaway (BRK.A) is a Sell

Is Berkshire Hathaway a Buy, Sell or Hold?

  • The current Berkshire Hathaway [BRK.A] share price is $757,400.00. The Score for BRK.A is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $16.93. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRK.A Stock Price Chart

What is Berkshire Hathaway's stock price today?

  • The Berkshire Hathaway share price today is $757,400.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $16.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5906.09 Sell
Relative Strength Index (14 RSI): 44.03 Sell
Chaikin Money Flow: 204 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (772419.95 - 772451.95) Sell
Bollinger Bands (100): (749323.5 - 749399.5) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: -1004786 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.86 - 18.96) Sell
Bollinger Bands (100): (18.68 - 28.96) Sell

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 758168.98 Sell
20-day SMA: 766005.43 Sell
50-day SMA: 777600.93 Sell
200-day SMA: 719303.98 Buy
8-day EMA: 759045.98 Sell
20-day EMA: 765211.2 Sell
50-day EMA: 766545.68 Sell
200-day EMA: 720158.92 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.4 Sell
20-day SMA: 17.74 Sell
50-day SMA: 19.36 Sell
200-day SMA: 28.18 Sell
8-day EMA: 17.24 Sell
20-day EMA: 17.7 Sell
50-day EMA: 19.64 Sell
200-day EMA: 28.21 Sell

Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1,917.50 per share, a decrease next quarter of $1,787.00 per share, an increase this year of $1,115.14 per share, and an increase next year of $1,599.50 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Berkshire Hathaway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):